Balance Sheet Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 16:35:28 18/06/2025 BST			5-day change	1st Jan Change
27.20 ^EUR	+0.17%		+1.72%	+40.86%

06-17	Bayer Files for FDA Approval of Gadoquatrane	DJ
06-17	Bayer Seeks US FDA Nod for MRI Contrast Agent Gadoquatrane	MT

d2b481f60556d.DJ05lN3TbUcEmIiQSFZfJne7xU7KV46K44K5vQC1rlI.QqRq54mdXBIy-dfWewUzfBTi6HfzHbiyle77-kfg-B9I8UvdsqYBA2mo0Q

Published financial data: BAYER AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	41.4B	44.08B	50.74B	47.64B	46.61B
Total Revenues	41.4B	44.08B	50.74B	47.64B	46.61B
Cost of Goods Sold, Total	15.73B	17.04B	18.89B	19.75B	20.83B
Gross Profit	25.67B	27.04B	31.85B	27.89B	25.78B
Selling General & Admin Expenses, Total	13.89B	14.61B	16.04B	14.71B	16.76B
R&D Expenses	4.88B	5.33B	6.17B	5.84B	5.97B
Other Operating Expenses	28M	27M	528M	-457M	-130M
Other Operating Expenses, Total	18.8B	19.96B	22.73B	20.09B	22.61B
Operating Income	6.88B	7.07B	9.12B	7.8B	3.17B
Interest Expense, Total	-1.5B	-1.29B	-1.06B	-1.13B	-1.95B
Interest And Investment Income	202M	346M	379M	484M	521M
Net Interest Expenses	-1.3B	-940M	-679M	-650M	-1.42B
Income (Loss) On Equity Invest.	-96M	49M	-450M	-335M	-295M
Currency Exchange Gains (Loss)	-216M	-385M	-219M	-449M	-203M
Other Non Operating Income (Expenses)	102M	23M	-844M	-788M	1.46B
EBT, Excl. Unusual Items	5.37B	5.82B	6.93B	5.58B	2.71B
Restructuring Charges	-52M	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-2.24B	-	-734M	-6.69B	-3.26B
Gain (Loss) On Sale Of Investments	541M	-39M	-150M	-11M	-3M
Gain (Loss) On Sale Of Assets	34M	86M	-	-	-
Asset Writedown	92M	132M	1.69B	152M	155M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-13.33B	-3.69B	-791M	-889M	-548M
Other Unusual Items	-7.66B	-262M	-2.28B	240M	-1.38B
EBT, Incl. Unusual Items	-17.25B	2.05B	4.67B	-1.62B	-2.33B
Income Tax Expense	-1.69B	1.02B	504M	1.32B	212M
Earnings From Continuing Operations	-15.56B	1.02B	4.17B	-2.94B	-2.55B
Earnings Of Discontinued Operations	5.07B	-	-	-	-
Net Income to Company	-10.49B	1.02B	4.17B	-2.94B	-2.55B
Minority Interest	-8M	-22M	-16M	1M	-6M
Net Income - (IS)	-10.5B	1B	4.15B	-2.94B	-2.55B
Net Income to Common Incl Extra Items	-10.5B	1B	4.15B	-2.94B	-2.55B
Net Income to Common Excl. Extra Items	-15.57B	1B	4.15B	-2.94B	-2.55B
Per Share Items
Net EPS - Basic	-10.68	1.02	4.22	-2.99	-2.6
Basic EPS - Continuing Operations	-15.85	1.02	4.22	-2.99	-2.6
Basic Weighted Average Shares Outstanding	982M	982M	982M	982M	982M
Net EPS - Diluted	-10.69	1.02	4.22	-2.99	-2.6
Diluted EPS - Continuing Operations	-15.85	1.02	4.22	-2.99	-2.6
Diluted Weighted Average Shares Outstanding	982M	982M	982M	982M	982M
Normalized Basic EPS	3.41	3.68	4.39	3.55	1.72
Normalized Diluted EPS	3.41	3.68	4.39	3.55	1.72
Dividend Per Share	2	2	2.4	0.11	0.11
Payout Ratio	-26.21	199.3	47.83	-80.89	-4.23
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	9.93B	8.34B	12.7B	11.33B	6.86B
EBITA	8.7B	7.19B	11.52B	10.12B	5.62B
EBIT	6.88B	7.07B	9.12B	7.8B	3.17B
EBITDAR	10.2B	8.63B	13.15B	11.79B	7.33B
Effective Tax Rate - (Ratio)	9.79	50.05	10.79	-81.49	-9.08
Current Domestic Taxes	718M	604M	912M	359M	58M
Current Foreign Taxes	569M	1.02B	1.66B	884M	887M
Total Current Taxes	1.29B	1.63B	2.57B	1.24B	945M
Total Deferred Taxes	-2.98B	-602M	-2.07B	78M	-733M
Normalized Net Income	3.35B	3.61B	4.31B	3.49B	1.69B
Interest Capitalized	34M	30M	38M	53M	61M
Interest on Long-Term Debt	-	-	-	72M	77M
Non-Cash Pension Expense	92M	62M	78M	125M	87M
Supplemental Operating Expense Items
Selling and Marketing Expenses	11.62B	12.27B	13.55B	12.57B	13.09B
General and Administrative Expenses	2.17B	2.26B	2.49B	2.14B	2.18B
Research And Development Expense From Footnotes	8.53B	5.72B	7.4B	5.63B	6.39B
Net Rental Expense, Total	271M	286M	447M	461M	468M
Imputed Operating Lease Interest Expense	82.26M	72.87M	94.98M	101M	175M
Imputed Operating Lease Depreciation	189M	213M	352M	360M	293M
Stock-Based Comp., Other (Total)	63M	238M	365M	153M	58M
Total Stock-Based Compensation	63M	238M	365M	153M	58M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	4.19B	4.56B	5.17B	5.91B	6.19B
Short Term Investments	1.31B	669M	32M	755M	75M
Trading Asset Securities, Total	6.38B	2.51B	4.95B	3.92B	1.82B
Total Cash And Short Term Investments	11.88B	7.74B	10.15B	10.59B	8.09B
Accounts Receivable, Total	9.56B	10.05B	10.32B	9.35B	8.97B
Other Receivables	2.59B	2.93B	3.13B	3.17B	3.22B
Notes Receivable	-	-	-	-	-
Total Receivables	12.14B	12.98B	13.45B	12.52B	12.19B
Inventory	10.96B	11.31B	13.64B	13.95B	13.47B
Other Current Assets, Total	673M	545M	521M	500M	702M
Total Current Assets	35.66B	32.58B	37.76B	37.56B	34.44B
Gross Property Plant And Equipment	23.63B	26.19B	28.34B	29.26B	31.22B
Accumulated Depreciation	-11.92B	-13.5B	-14.66B	-15.94B	-17.77B
Net Property Plant And Equipment	11.71B	12.69B	13.67B	13.32B	13.46B
Long-term Investments	2B	2.61B	2.9B	3.06B	3.02B
Goodwill	36.08B	40.11B	39.65B	32.3B	30.02B
Other Intangibles, Total	21.64B	21.96B	20.42B	19.82B	18.43B
Accounts Receivable Long-Term	1M	24M	24M	23M	20M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	4.69B	4.58B	5.6B	5.47B	6.16B
Deferred Charges Long-Term	4.42B	4.31B	3.8B	3.56B	3.72B
Other Long-Term Assets, Total	853M	1.38B	1.06B	1.15B	1.58B
Total Assets	117B	120B	125B	116B	111B
Liabilities
Accounts Payable, Total	5.68B	6.79B	7.54B	7.46B	7.52B
Accrued Expenses, Total	2.57B	3.5B	3.57B	2.5B	3.49B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	8.36B	4.16B	7.58B	6.54B	5B
Current Portion of Leases	212M	236M	282M	294M	309M
Current Income Taxes Payable	2.27B	686M	1.06B	619M	547M
Unearned Revenue Current, Total	3.63B	4.09B	4.2B	3.91B	3.68B
Other Current Liabilities	14B	9.94B	10.85B	8.15B	8.4B
Total Current Liabilities	36.73B	29.4B	35.08B	29.46B	28.95B
Long-Term Debt	32.27B	35.55B	32.84B	37.23B	34.56B
Long-Term Leases	925M	929M	952M	944M	939M
Unearned Revenue Non Current	743M	810M	602M	467M	343M
Pension & Other Post Retirement Benefits	8.45B	7.18B	4.39B	4.01B	3.31B
Deferred Tax Liability Non Current	1.33B	931M	727M	790M	865M
Other Non Current Liabilities	5.9B	12.27B	11.36B	10.28B	9.84B
Total Liabilities	86.35B	87.07B	85.95B	83.18B	78.8B
Common Stock, Total	2.52B	2.52B	2.52B	2.52B	2.52B
Retained Earnings	13.06B	13.34B	17.23B	12.18B	9.87B
Comprehensive Income and Other	14.95B	17.16B	19.02B	18.24B	19.53B
Total Common Equity	30.52B	33.02B	38.77B	32.93B	31.91B
Minority Interest	175M	148M	153M	151M	137M
Total Equity	30.7B	33.17B	38.93B	33.08B	32.04B
Total Liabilities And Equity	117B	120B	125B	116B	111B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	982M	982M	982M	982M	982M
ECS Total Common Shares Outstanding	982M	982M	982M	982M	982M
Book Value / Share	31.07	33.61	39.47	33.52	32.48
Tangible Book Value	-27.2B	-29.04B	-21.29B	-19.19B	-16.54B
Tangible Book Value Per Share	-27.68	-29.56	-21.67	-19.54	-16.83
Total Debt	41.77B	40.87B	41.65B	45.01B	40.81B
Net Debt	29.88B	33.13B	31.5B	34.42B	32.72B
Debt Equivalent of Unfunded Proj. Benefit Obligation	7.96B	6.26B	3.58B	3.06B	1.91B
Debt Equivalent Oper. Leases	2.17B	2.29B	3.58B	3.69B	3.74B
Minority Interest, Total (Incl. Fin. Div)	175M	148M	153M	151M	137M
Equity Method Investments, Total	491M	629M	893M	850M	820M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	2.65B	2.01B	2.7B	2.52B	2.08B
Inventories - Work In Process, Total	8.21B	9.16B	10.72B	11.29B	11.23B
Inventories - Others	99M	139M	221M	140M	152M
Land - (BS)	9.07B	9.83B	10.48B	10.74B	11.57B
Machinery, Total	11.99B	13.24B	14.58B	15.35B	16.64B
Full Time Employees	95.96K	95.95K	97.92K	96.93K	91.86K
Accumulated Allowance for Doubtful Accounts (Supple)	621M	654M	700M	642M	576M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-10.5B	1B	4.15B	-2.94B	-2.55B
Depreciation & Amortization - CF	1.62B	1.49B	1.54B	1.59B	1.6B
Amortization of Goodwill and Intangible Assets - (CF)	1.82B	117M	2.4B	2.32B	2.45B
Depreciation & Amortization, Total	3.44B	1.61B	3.95B	3.91B	4.05B
(Gain) Loss From Sale Of Asset	-126M	-217M	-1.69B	-152M	-207M
Asset Writedown & Restructuring Costs	9.82B	1.45B	2.55B	6.11B	4.73B
Net Cash From Discontinued Operations	334M	-	-	-	-
Other Operating Activities, Total	-6.74B	194M	828M	2.26B	1.26B
Change In Accounts Receivable	695M	-61M	269M	689M	197M
Change In Inventories	-900M	-173M	-2.17B	-430M	521M
Change In Accounts Payable	-347M	854M	612M	82M	-120M
Change in Other Net Operating Assets	9.22B	436M	-1.41B	-4.41B	-513M
Cash from Operations	4.9B	5.09B	7.09B	5.12B	7.37B
Capital Expenditure	-2.42B	-2.61B	-2.95B	-2.75B	-2.78B
Sale of Property, Plant, and Equipment	329M	373M	1.13B	215M	295M
Cash Acquisitions	-2.26B	-1.34B	-89M	-662M	-184M
Divestitures	4.17B	-6M	2.29B	8M	17M
Investment in Marketable and Equity Securities, Total	-4.03B	4.3B	-2.98B	-306M	2.32B
Other Investing Activities, Total	134M	137M	218M	-21M	489M
Cash from Investing	-4.07B	855M	-2.38B	-3.52B	164M
Long-Term Debt Issued, Total	10.89B	6.59B	6.63B	16.28B	5.82B
Total Debt Issued	10.89B	6.59B	6.63B	16.28B	5.82B
Long-Term Debt Repaid, Total	-6.42B	-9.04B	-7.6B	-13.03B	-10.83B
Total Debt Repaid	-6.42B	-9.04B	-7.6B	-13.03B	-10.83B
Issuance of Common Stock	-	-	-	23M	-
Repurchase of Common Stock	-	-	-10M	-24M	-16M
Common Dividends Paid	-2.75B	-1.99B	-1.98B	-2.38B	-108M
Common & Preferred Stock Dividends Paid	-2.75B	-1.99B	-1.98B	-2.38B	-108M
Other Financing Activities, Total	-1.29B	-1.2B	-1.25B	-1.55B	-2.04B
Cash from Financing	423M	-5.64B	-4.22B	-679M	-7.18B
Foreign Exchange Rate Adjustments	-240M	35M	112M	-185M	-68M
Miscellaneous Cash Flow Adjustments	-7M	39M	3M	-	-2M
Net Change in Cash	1.01B	373M	607M	736M	284M
Supplemental Items
Cash Interest Paid	1.3B	1.23B	1.3B	1.54B	1.98B
Cash Income Tax Paid (Refund)	1.06B	2.16B	2.03B	1.77B	1.22B
Levered Free Cash Flow	14.83B	-1.38B	5.85B	1.52B	3.72B
Unlevered Free Cash Flow	15.77B	-579M	6.51B	2.23B	4.93B
Change In Net Working Capital	-10.38B	4.23B	557M	3.96B	-1.62B
Net Debt Issued / Repaid	4.47B	-2.45B	-974M	3.25B	-5.02B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.53	3.73	4.65	4.04	1.74
Return on Total Capital	5.41	6.03	7.37	6.14	2.62
Return On Equity %	-39.83	3.2	11.56	-8.17	-7.82
Return on Common Equity	-40.03	3.15	11.56	-8.2	-7.87
Margin Analysis
Gross Profit Margin %	62.01	61.33	62.78	58.55	55.3
SG&A Margin	33.54	33.15	31.6	30.89	35.97
EBITDA Margin %	23.99	18.92	25.04	23.79	14.71
EBITA Margin %	21	16.31	22.71	21.23	12.06
EBIT Margin %	16.61	16.04	17.98	16.37	6.8
Income From Continuing Operations Margin %	-37.59	2.32	8.21	-6.18	-5.46
Net Income Margin %	-25.35	2.27	8.18	-6.17	-5.48
Net Avail. For Common Margin %	-37.61	2.27	8.18	-6.17	-5.48
Normalized Net Income Margin	8.08	8.2	8.5	7.32	3.62
Levered Free Cash Flow Margin	35.82	-3.14	11.52	3.19	7.97
Unlevered Free Cash Flow Margin	38.09	-1.31	12.83	4.68	10.58
Asset Turnover
Asset Turnover	0.34	0.37	0.41	0.4	0.41
Fixed Assets Turnover	3.42	3.61	3.85	3.53	3.48
Receivables Turnover (Average Receivables)	3.9	4.5	4.98	4.84	5.09
Inventory Turnover (Average Inventory)	1.46	1.53	1.51	1.43	1.52
Short Term Liquidity
Current Ratio	0.97	1.11	1.08	1.27	1.19
Quick Ratio	0.65	0.7	0.67	0.78	0.7
Operating Cash Flow to Current Liabilities	0.13	0.17	0.2	0.17	0.25
Days Sales Outstanding (Average Receivables)	93.86	81.17	73.26	75.34	71.94
Days Outstanding Inventory (Average Inventory)	251.47	238.5	241.1	254.93	240.83
Average Days Payable Outstanding	138.17	130.81	123.37	136.5	134.65
Cash Conversion Cycle (Average Days)	207.16	188.86	190.99	193.77	178.12
Long Term Solvency
Total Debt/Equity	136.05	123.23	107	136.06	127.36
Total Debt / Total Capital	57.64	55.2	51.69	57.64	56.02
LT Debt/Equity	108.13	109.99	86.81	115.41	110.78
Long-Term Debt / Total Capital	45.81	49.27	41.94	48.89	48.72
Total Liabilities / Total Assets	73.77	72.42	68.83	71.55	71.09
EBIT / Interest Expense	4.58	5.5	8.62	6.88	1.63
EBITDA / Interest Expense	6.88	6.75	12.35	10.32	3.71
(EBITDA - Capex) / Interest Expense	5.27	4.72	9.57	7.9	2.28
Total Debt / EBITDA	4.05	4.71	3.19	3.84	5.66
Net Debt / EBITDA	2.9	3.82	2.41	2.94	4.53
Total Debt / (EBITDA - Capex)	5.29	6.73	4.12	5.02	9.2
Net Debt / (EBITDA - Capex)	3.78	5.46	3.11	3.84	7.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.93	6.48	15.1	-6.11	-2.16
Gross Profit, 1 Yr. Growth %	-5.34	5.31	17.82	-12.44	-7.78
EBITDA, 1 Yr. Growth %	-8.11	-16.83	16.81	-10.81	-34.78
EBITA, 1 Yr. Growth %	-6.82	-18.25	19.33	-12.23	-39.55
EBIT, 1 Yr. Growth %	-1.5	1.42	22.02	-14.49	-54.65
Earnings From Cont. Operations, 1 Yr. Growth %	-745.68	-106.57	307.63	-170.62	-13.46
Net Income, 1 Yr. Growth %	-356.54	-109.53	315	-170.87	-13.23
Normalized Net Income, 1 Yr. Growth %	-7.2	6.08	12.09	-19.19	-58.93
Diluted EPS Before Extra, 1 Yr. Growth %	-750.76	-106.42	314.58	-170.94	-13.15
Accounts Receivable, 1 Yr. Growth %	-18.17	5.22	2.64	-9.39	-4.01
Inventory, 1 Yr. Growth %	2.92	3.22	20.52	2.28	-3.44
Net Property, Plant and Equip., 1 Yr. Growth %	-6.16	8.23	7.77	-2.58	1.01
Total Assets, 1 Yr. Growth %	-7.23	2.94	3.86	-6.9	-4.65
Tangible Book Value, 1 Yr. Growth %	27.82	7.71	-26.68	-9.86	-13.84
Common Equity, 1 Yr. Growth %	-35.4	8.18	17.42	-15.08	-3.09
Cash From Operations, 1 Yr. Growth %	-40.26	3.79	39.38	-27.86	43.99
Capital Expenditures, 1 Yr. Growth %	-8.75	7.98	12.95	-6.71	0.98
Levered Free Cash Flow, 1 Yr. Growth %	156.07	-109.27	377.87	-74.03	426.27
Unlevered Free Cash Flow, 1 Yr. Growth %	130.29	-103.65	260.61	-65.78	187.2
Dividend Per Share, 1 Yr. Growth %	-28.57	0	20	-95.42	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.15	0.61	10.71	3.96	-4.16
Gross Profit, 2 Yr. CAGR %	4.14	-0.16	11.39	1.57	-10.05
EBITDA, 2 Yr. CAGR %	17.91	-12.15	12.55	2.07	-26.53
EBITA, 2 Yr. CAGR %	21.98	-12.24	14.49	2.34	-30.16
EBIT, 2 Yr. CAGR %	27.08	0.65	14.38	2.14	-41.07
Earnings From Cont. Operations, 2 Yr. CAGR %	234.59	-34.88	-48.26	69.67	-21.82
Net Income, 2 Yr. CAGR %	148.83	-50.56	-37.12	71.49	-21.58
Normalized Net Income, 2 Yr. CAGR %	28.68	0.11	12.53	-4.83	-37.49
Diluted EPS Before Extra, 2 Yr. CAGR %	229.49	-35.35	-48.4	71.49	-21.51
Accounts Receivable, 2 Yr. CAGR %	-9.68	-7.22	3.92	-3.57	-6.74
Inventory, 2 Yr. CAGR %	-0.77	3.07	11.54	11.03	-0.62
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.88	0.83	8	2.46	-0.8
Total Assets, 2 Yr. CAGR %	-3.9	-2.38	3.4	-1.67	-5.78
Tangible Book Value, 2 Yr. CAGR %	6.55	16.84	-11.14	-18.71	-11.87
Common Equity, 2 Yr. CAGR %	-18.52	-16.41	12.71	-0.14	-9.28
Cash From Operations, 2 Yr. CAGR %	-21.3	-21.25	20.28	0.27	1.92
Capital Expenditures, 2 Yr. CAGR %	-3.43	-0.74	10.44	2.65	-2.94
Levered Free Cash Flow, 2 Yr. CAGR %	75.82	-51.15	-37.39	11.4	-20.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	66.71	-70.93	-35.93	11.09	-12.95
Dividend Per Share, 2 Yr. CAGR %	-15.48	-15.48	9.54	-76.55	-78.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.74	6.26	5.23	4.79	1.87
Gross Profit, 3 Yr. CAGR %	2.56	4.53	5.51	2.8	-1.58
EBITDA, 3 Yr. CAGR %	3.36	5.3	5.53	4.15	-14.25
EBITA, 3 Yr. CAGR %	2.4	7.14	7.29	4.78	-16.51
EBIT, 3 Yr. CAGR %	0	18.43	9.33	3.81	-24.89
Earnings From Cont. Operations, 3 Yr. CAGR %	68.58	-9.74	20.01	-42.61	35.56
Net Income, 3 Yr. CAGR %	12.68	-16.13	0.48	-34.56	36.66
Normalized Net Income, 3 Yr. CAGR %	-3.41	21.38	6.16	0.77	-24.06
Diluted EPS Before Extra, 3 Yr. CAGR %	62.04	-11.33	20.11	-42.62	36.7
Accounts Receivable, 3 Yr. CAGR %	3.64	-4.97	-4.05	-0.72	-3.71
Inventory, 3 Yr. CAGR %	18.72	0.54	8.59	8.36	5.98
Net Property, Plant and Equip., 3 Yr. CAGR %	15.33	-0.66	3.1	4.35	1.98
Total Assets, 3 Yr. CAGR %	15.95	-1.74	-0.34	-0.16	-2.67
Tangible Book Value, 3 Yr. CAGR %	34	6.63	0.03	-10.71	-17.12
Common Equity, 3 Yr. CAGR %	-6.04	-10.45	-6.38	2.56	-1.14
Cash From Operations, 3 Yr. CAGR %	-15.53	-13.7	-4.75	1.43	13.13
Capital Expenditures, 3 Yr. CAGR %	0.73	0.23	3.63	4.39	2.09
Levered Free Cash Flow, 3 Yr. CAGR %	50.09	-33.95	0.32	-53.31	44.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	48.5	-53.28	-1.68	-48.02	39.81
Dividend Per Share, 3 Yr. CAGR %	-10.61	-10.61	-5.01	-61.97	-61.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.12	4.76	7.7	5.33	1.37
Gross Profit, 5 Yr. CAGR %	0.15	2.76	6.01	3.33	-1.01
EBITDA, 5 Yr. CAGR %	0.11	-1.32	7.15	9.66	-8.7
EBITA, 5 Yr. CAGR %	0.55	-2.3	7.31	11.6	-9.64
EBIT, 5 Yr. CAGR %	0.3	1.52	5.82	12.87	-14.62
Earnings From Cont. Operations, 5 Yr. CAGR %	31.13	-22.92	5.1	16.18	1.1
Net Income, 5 Yr. CAGR %	20.62	-26.08	-10.77	11.65	-9.01
Normalized Net Income, 5 Yr. CAGR %	-2.39	-0.07	3.05	11.53	-14.11
Diluted EPS Before Extra, 5 Yr. CAGR %	26.63	-25.7	2.52	15.44	1.32
Accounts Receivable, 5 Yr. CAGR %	-0.77	-1.73	3.75	-4.41	-5.13
Inventory, 5 Yr. CAGR %	5.09	6.12	15.79	4.61	4.81
Net Property, Plant and Equip., 5 Yr. CAGR %	-1.1	-0.66	12.37	0.58	1.52
Total Assets, 5 Yr. CAGR %	9.63	7.89	10.71	-1.71	-2.56
Tangible Book Value, 5 Yr. CAGR %	34.03	92.25	13.5	-4.33	-4.92
Common Equity, 5 Yr. CAGR %	4.7	1.71	1.05	-6.46	-7.55
Cash From Operations, 5 Yr. CAGR %	-6.58	-10.95	-2.7	-8.36	-2.13
Capital Expenditures, 5 Yr. CAGR %	-0.8	0.25	4.5	1.19	0.95
Levered Free Cash Flow, 5 Yr. CAGR %	26.97	-5.13	5.92	-20.55	-8.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	25.92	-23.5	6.21	-17.06	-6.35
Dividend Per Share, 5 Yr. CAGR %	-4.36	-5.83	-3.04	-47.66	-47.66